Workflow
Zhejiang Yangfan New Materials (300637)
icon
Search documents
扬帆新材:浙江六和律师事务所关于浙江扬帆新材料股份有限公司2023年年度股东大会法律意见书
2024-05-22 11:49
浙江六和律师事务所 关于浙江扬帆新材料股份有限公司2023年年度股东大会 法律意见书 浙六和法意(2024)第776号 致:浙江扬帆新材料股份有限公司 根据《中华人民共和国公司法》(下称"《公司法》")《中华人民共和 国证券法》(下称"《证券法》")和中国证券监督管理委员会发布的《上市 公司股东大会规则》(下称"《规则》")等法律法规、规范性文件以及《浙 江扬帆新材料股份有限公司章程》(下称"《公司章程》")《浙江扬帆新材 料股份有限公司股东大会议事规则》(下称"《议事规则》")的规定,浙江 六和律师事务所接受浙江扬帆新材料股份有限公司 (以下简称"公司")委托, 指派金文杰律师、宁平律师(以下简称"本所律师")出席公司于2024年5月22日 14:00在浙江省杭州市滨江区信诚路31号扬帆大厦三楼会议室召开的2023年年度 股东大会(下称"本次股东大会"),对本次股东大会的召集、召开程序、出 席会议人员资格、会议表决方式和程序以及会议决议的有效性等事宜出具本法 律意见书。 为出具本法律意见书,本所律师对本次股东大会所涉及的有关事项进行了 审查,查阅了本所律师认为出具本法律意见书所必须的文件、资料,并对有关 事 ...
扬帆新材:2023年年度股东大会决议公告
2024-05-22 11:49
证券代码:300637 证券简称:扬帆新材 公告编号:2024-029 浙江扬帆新材料股份有限公司 2023 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 特别提示: 1.本次股东大会未出现否决议案的情况; 2.本次股东大会无涉及变更以往股东大会已通过的决议; 3.本次股东大会以现场投票和网络投票相结合的方式召开。 一、会议召开和出席情况 (一)会议召开情况 1、股东出席的总体情况:通过现场和网络投票的股东 12 人,代表股份 100,124,920 股,占上市公司总股份的 42.6517%。其中:通过现场投票的股东 8 人,代表股份 100,103,520 股,占上市公司总股份的 42.6426%。通过网络投票的 股东 4 人,代表股份 21,400 股,占上市公司总股份的 0.0091%。 2、中小股东出席的总体情况:通过现场和网络投票的中小股东 6 人,代表 股份 10,890,860 股,占上市公司总股份的 4.6393%。其中:通过现场投票的中小 股东 2 人,代表股份 10,869,460 股,占上市公司总股份的 4.63 ...
扬帆新材:关于为子公司提供担保的进展公告
2024-05-09 09:15
证券代码:300637 证券简称:扬帆新材 公告编号:2024-028 浙江扬帆新材料股份有限公司 为满足公司及合并报表范围内的子公司日常经营和业务发展资金需要,提高公司融 资决策效率,公司计划在授权期限内为合并报表范围内的内蒙古扬帆新材料有限公司、 浙江寿尔福化工贸易有限公司、江西扬帆新材料有限公司担保合计最高余额不超过折合 人民币 8 亿元。 担保授权期限自公司 2022 年年度股东大会审议通过之日起至公司 2023 年年度股东 大会召开之日止。该额度在以上期限内可循环使用。具体内容详见同日登载于巨潮资讯 网的《关于 2023 年度对外担保额度预计的公告》(2023-014)。 二、担保的进展情况 近日,公司与江西农村商业银行股份有限公司黄花支行签署了《保证合同》,就公司 子公司江西扬帆新材料有限公司(以下简称"江西扬帆")向江西农村商业银行股份有限 公司黄花支行(以下简称"江西农商")的 4,000 万元借款承担保证责任。 根据《深圳证券交易所创业板股票上市规则》等相关文件的规定,本次担保金额在 预计担保额度范围之内。 三、被担保人基本情况 公司名称:江西扬帆新材料有限公司 关于为子公司提供担保的进展公 ...
扬帆新材(300637) - 2024 Q1 - 季度财报
2024-04-28 07:44
Financial Performance - The company's revenue for Q1 2024 was ¥132,894,992.92, a decrease of 15.98% compared to ¥158,164,544.68 in the same period last year[5] - The net profit attributable to shareholders was a loss of ¥13,434,631.70, an improvement of 10.66% from a loss of ¥15,037,349.28 in the previous year[5] - Total operating revenue for Q1 2024 was CNY 132,894,992.92, a decrease of 16.0% compared to CNY 158,164,544.68 in the same period last year[19] - Net loss for Q1 2024 was CNY 13,434,631.70, an improvement from a net loss of CNY 15,037,349.28 in Q1 2023[21] - Basic and diluted earnings per share were both CNY -0.0572, an improvement from CNY -0.0641 in Q1 2023[22] Cash Flow - The net cash flow from operating activities was ¥5,086,231.91, a significant increase of 175.62% compared to a negative cash flow of ¥6,725,878.10 in the same period last year[5] - Operating cash flow generated was CNY 5,086,231.91, compared to a negative cash flow of CNY -6,725,878.10 in the previous year[24] - The net cash flow from financing activities for Q1 2024 was -9,409,934.31, compared to 39,064,798.93 in the previous year[25] - The net increase in cash and cash equivalents for Q1 2024 was -3,415,478.78, compared to an increase of 12,937,597.92 in the same period last year[25] Assets and Liabilities - The company's total assets at the end of the reporting period were ¥1,324,995,262.75, showing no significant change from ¥1,324,949,102.95 at the end of the previous year[5] - Total current assets decreased from 408,077,065.27 RMB to 398,602,258.34 RMB, a reduction of approximately 1.16%[15] - Total liabilities decreased from 631,888,268.83 RMB to 625,785,092.35 RMB, a reduction of about 0.17%[17] - Non-current liabilities decreased significantly from 154,532,929.80 RMB to 64,322,445.58 RMB, a decrease of approximately 58%[17] - Total assets remained relatively stable, with a slight increase from 1,324,949,102.95 RMB to 1,324,995,262.75 RMB[16] Shareholder Information - Total number of common shareholders at the end of the reporting period is 28,148[11] - Zhejiang Yangfan Holding Group Co., Ltd. holds 22.04% of shares, totaling 51,729,200 shares, with 25,860,000 shares pledged[11] - SFC CO., LTD. holds 15.84% of shares, totaling 37,175,400 shares[11] Research and Development - Research and development expenses decreased by 13.59% to ¥8,931,419.48 from ¥10,335,803.87 in the previous year[8] - Research and development expenses were CNY 8,931,419.48, down 13.6% from CNY 10,335,803.87 in the prior year[19] Other Income and Expenses - The company reported a 52.74% decrease in other income, totaling ¥907,230.45 compared to ¥1,919,557.33 in the previous year[8] - The company received government subsidies amounting to ¥588,596.15 during the reporting period[6] - Total operating costs decreased to CNY 151,237,475.73, down 15.4% from CNY 178,721,649.09 year-on-year[19] Cash and Cash Equivalents - Cash and cash equivalents decreased from 104,262,745.42 RMB to 96,348,456.79 RMB, a decline of about 7.3%[15] - The beginning balance of cash and cash equivalents was 99,750,656.10, compared to 63,803,309.48 at the start of the previous year[25] - The ending balance of cash and cash equivalents for Q1 2024 was 96,335,177.32, compared to 76,740,907.40 in Q1 2023[25] Other Information - The company has not reported any new product developments or market expansion strategies in this quarter[12] - The Q1 2024 report has not been audited[26]
扬帆新材:第四届监事会第十一次会议会议公告
2024-04-28 07:44
证券代码:300637 证券简称:扬帆新材 公告编号:2024-027 一、审议通过《关于 2024 年第一季度报告的议案》 监事会认为:公司 2024 年第一季度报告的编制和审议程序符合相关法律、 法规和公司内部各项制度的规定;报告内容真实、准确、完整地反映了公司 2024 年第一季度经营的实际情况,不存在任何虚假记载、误导性陈述或者重大遗漏。 表决情况:3 票同意,0 票反对,0 票弃权;获全体监事一致通过。 详见同日刊登在中国证监会指定创业板信息披露网站巨潮资讯网上的相关 公告。 特此公告。 浙江扬帆新材料股份有限公司 第四届监事会第十一次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 浙江扬帆新材料股份有限公司第四届监事会第十一次会议于 2024 年 4 月 25 日下午在浙江省杭州市滨江区信诚路 31 号扬帆大厦 5 楼会议室召开。公司已于 会议召开 48 小时前以通讯方式通知全体监事。会议应出席监事 3 名,实际出席 监事 3 名。会议召开符合《中华人民共和国公司法》及相关法律、法规、规章及 《浙江扬帆新材料股份有限公司章程》的规定。 ...
扬帆新材:第四届董事会第十二次会议决议公告
2024-04-28 07:44
浙江扬帆新材料股份有限公司 第四届董事会第十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 浙江扬帆新材料股份有限公司第四届董事会第十二次会议于 2024 年 4 月 25 日上午在杭州市滨江区信诚路 31 号扬帆大厦五楼会议室召开。公司已于会议召开 48 小时前以通讯方式通知全体董事。会议应出席董事 6 名,实际出席董事 6 名。 会议召开符合《中华人民共和国公司法》及相关法律法规、规范性文件及《浙江 扬帆新材料股份有限公司章程》的规定。 本次会议由董事长樊彬先生召集并主持,部分监事及高级管理人员列席会议。 经与会董事审议,审议通过如下议案: 证券代码:300637 证券简称:扬帆新材 公告编号:2024-026 表决结果:6 票同意;0 票反对;0 票弃权,获全票通过。 详见同日刊登在中国证监会指定创业板信息披露网站巨潮资讯网上的相关公 告。 浙江扬帆新材料股份有限公司董事会 2024 年 4 月 29 日 一、审议通过《关于 2024 年第一季度报告的议案》 经审议,董事会认为:公司 2024 年第一季度报告所载资料内容真实、准确、 完 ...
扬帆新材:募集资金管理制度
2024-04-23 13:43
第三条 公司董事会负责建立健全公司募集资金管理制度,并确保该制度的有 效实施。公司的董事、监事和高级管理人员应当勤勉尽责,督促公司规范使用募集资 金,自觉维护公司募集资金安全,不得参与、协助或纵容公司擅自或变相改变募集资 金用途。 第四条 募集资金投资项目通过公司的子公司或公司控制的其他企业实施的, 相应的子公司或公司控制的其他企业应遵守本制度的各项规定。 浙江扬帆新材料股份有限公司 募集资金管理制度 (2024 年 4 月) 第一章 总 则 第一条 为规范浙江扬帆新材料股份有限公司(以下简称"公司")募集资金的 管理和使用,提高募集资金使用的效率和效果,防范资金使用风险,确保资金使用安 全,根据《中华人民共和国公司法》、《中华人民共和国证券法》、《上市公司监管指引 第 2 号——上市公司募集资金管理和使用的监管要求》、《深圳证券交易所创业板股票 上市规则》、《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范 运作》作指引》等有关法律、法规和规范性文件以及《浙江扬帆新材料股份有限公司 章程》(以下简称"《公司章程》"),制定本制度。 第二条 本制度所称募集资金是指公司通过公开发行证券(包括首 ...
扬帆新材:2023年年度审计报告
2024-04-23 13:43
| | | | | 页 次 | | --- | --- | | 一、审计报告 | 1-7 | | 二、财务报表 | 8-19 | | (一) 合并资产负债表 | 8-9 | | (二) 合并利润表 | 10 | | (三) 合并现金流量表 | 11 | | (四) 合并所有者权益变动表 | 12-13 | | (五) 母公司资产负债表 | 14-15 | | (六) 母公司利润表 | 16 | | (七) 母公司现金流量表 | 17 | | (八) 母公司所有者权益变动表 | 18-19 | 三、财务报表附注 20-125 审 计 报 告 中汇会审[2024]4625号 浙江扬帆新材料股份有限公司全体股东: 一、审计意见 我们审计了浙江扬帆新材料股份有限公司(以下简称扬帆新材料公司)财务 报表,包括2023年12月31日的合并及母公司资产负债表,2023年度的合并及母公 司利润表、合并及母公司现金流量表、合并及母公司所有者权益变动表以及财务 报表附注。 我们认为,后附的财务报表在所有重大方面按照企业会计准则的规定编制, 公允反映了扬帆新材料公司2023年12月31日的合并及母公司财务状况以及2023 年度的合 ...
扬帆新材(300637) - 2023 Q4 - 年度财报
2024-04-23 13:43
Financial Performance - The company reported a loss during the reporting period due to global geopolitical conflicts, macroeconomic conditions, and industry cycles, with lower production than expected, consistent with overall industry performance [5]. - The company's operating revenue for 2023 was ¥691,315,141.33, a decrease of 12.71% compared to ¥791,936,854.53 in 2022 [22]. - The net profit attributable to shareholders for 2023 was -¥87,732,028.73, representing a decline of 1,645.60% from ¥5,676,252.39 in 2022 [22]. - The net cash flow from operating activities decreased by 71.31% to ¥21,788,647.84 in 2023, down from ¥75,950,451.02 in 2022 [22]. - The total assets at the end of 2023 were ¥1,324,949,102.95, a reduction of 4.64% from ¥1,389,429,540.68 at the end of 2022 [22]. - The company reported a basic earnings per share of -¥0.3737 for 2023, compared to ¥0.0242 in 2022, marking a decline of 1,644.21% [22]. - The company reported a net loss of 87.73 million yuan, a decline of 93.41 million yuan year-on-year, primarily due to high product costs and increased asset impairment losses [77]. - The total revenue for 2023 was ¥691,315,141.33, representing a decrease of 12.71% compared to ¥791,936,854.53 in 2022 [86]. Strategic Initiatives - The company plans not to distribute cash dividends, issue bonus shares, or increase share capital from reserves [6]. - The company will take a series of measures to improve profitability, as detailed in the management discussion and analysis section of the report [5]. - The company is focusing on improving its operational efficiency and exploring new strategies for market expansion and product development [5]. - Future outlook includes a cautious approach to market conditions and potential recovery strategies [5]. - The company is actively assessing new product and technology developments to enhance its competitive position [5]. - The company is monitoring industry trends and competitive dynamics to adapt its strategies accordingly [5]. - The company aims to leverage its full industry chain advantages to enhance its position as a major supplier of photoinitiators and thiol compounds globally [32]. - The company has initiated strategic expansion towards phosphorus fine chemicals, indicating a shift in its product development focus [32]. Market Trends and Opportunities - The radiation curing industry is expected to grow, driven by technological advancements and increasing demand for environmentally friendly products [33]. - The market is increasingly favoring new types of photoinitiators that are compatible with UV LED light sources, particularly those in the narrow wavelength range closer to visible light, such as cationic photoinitiators [37]. - Since 2015, various policies have been implemented in China to promote the development of environmentally friendly materials, including radiation curing materials, which are expected to gradually replace traditional ink materials [38]. - The application of radiation curing technology is rapidly expanding, with downstream products such as UV coatings, UV inks, and UV adhesives seeing significant growth [39]. - The global 3D printing market is projected to grow at a compound annual growth rate (CAGR) of 17% from 2020 to 2023, reaching a market size of over $37 billion by 2026, driving demand for photoinitiators [41]. - The Chinese pharmaceutical market is expected to reach RMB 2.3 trillion by 2025, with a CAGR of 7.20% from 2021 to 2025, increasing the demand for pharmaceutical intermediates [44]. - The global pesticide market is projected to grow from $35.68 billion in 2004 to $66.70 billion in 2023, indicating a steady demand for pesticide intermediates [45]. - The Chinese medical intermediate market is expected to exceed RMB 290 billion by 2026, reflecting a growing demand for intermediates in the pharmaceutical sector [44]. Research and Development - The company has a total of 48 authorized patents, including 10 invention patents and 31 for intermediates, supporting its R&D capabilities [54]. - The company has established a close cooperation with universities such as Zhejiang University and Tongji University to enhance its R&D capabilities [60]. - The company is focusing on the research and development of phosphorus and sulfur-containing fine chemicals, which are essential in various applications including green pesticides and pharmaceuticals [50]. - The company has achieved significant research results in the sustainable manufacturing of phosphorus-sulfur compounds, contributing to environmental protection and resource recycling [50]. - The company is focusing on developing new products, including high-refractive-index monomers and new photoinitiators, with several products already recognized by customers and expected to scale up production [82]. - The company has completed the development of 1 new pharmaceutical intermediate product, enhancing its market competitiveness in hormone compounds [103]. Operational Efficiency - The company implemented cost control measures and optimized organizational structure to enhance operational efficiency and reduce management costs [80]. - The company maintains a production model based on "sales-driven production," adjusting production plans according to customer orders and market trends [72]. - The company has established a comprehensive new product development management process, ensuring effective control over the R&D stages [75]. - The company has completed several technical transformation projects at its main production bases, creating favorable conditions for future production increases [80]. - The company is focusing on maximizing capacity utilization rates and ensuring stable operations across its production bases, including Inner Mongolia, Jiangxi, and Shangyu, to achieve expected returns [139]. Environmental Responsibility - The company emphasizes safety and environmental protection, adhering to relevant laws and regulations, and promoting clean production and green processes [62][64]. - The company holds environmental permits valid until July 2028 for its subsidiaries, ensuring compliance with pollution control standards [199]. - The company’s wastewater discharge of COD was reported at 19.65 tons, with a concentration of 289.97 mg/l, below the standard limit of 500 mg/l [199]. - The company’s ammonia nitrogen (NH3-N) discharge was 0.38 tons, with a concentration of 5.56 mg/l, also below the standard limit of 50 mg/l [199]. - The company’s volatile organic compounds (VOCs) emissions were recorded at 0.67 tons, with a concentration of 3.81 mg/m3, well below the limit of 80 mg/m3 [199]. - The company has implemented continuous monitoring of emissions, ensuring that all pollutants are within regulatory limits, thus enhancing its environmental responsibility [200]. Governance and Management - The company has a well-defined organizational structure and governance system, allowing for independent and coordinated operations across departments [158]. - The company has established an independent financial department with a complete accounting system, ensuring independent financial decision-making and tax compliance [158]. - The board of directors consists of 6 members, including 3 independent directors [164]. - The company has a supervisory board with 3 members, including 1 employee representative [167]. - The senior management team comprises 6 individuals, with diverse backgrounds in engineering and finance [169]. - The company emphasizes the importance of independent directors in its governance structure [166]. - The management team is committed to driving innovation and operational efficiency in the new materials sector [169]. Employee Development - The company has implemented a performance evaluation mechanism to ensure employee compensation reflects their contributions, aiming to enhance competitiveness in the talent market [185]. - A training program was established for new hires, particularly recent graduates, to facilitate their transition into the workforce [188]. - The company conducted online training courses for mid-level management to improve their management skills and overall capabilities [188]. - The total number of employees at the end of the reporting period was 935, with 212 in the parent company and 723 in major subsidiaries [184]. - The company has focused on enhancing employee skills through regular training in production techniques and safety awareness [189]. Risks and Challenges - The company faces risks from international political instability and upstream raw material price fluctuations, which could impact production and profitability [134][136]. - The company is addressing potential risks from downstream market conditions by expanding sales channels and adapting products to meet diverse industry needs [137]. - The company is facing intensified market competition due to the rapid expansion of the photoinitiator market, which has led to an influx of competitors and potential risks of excess capacity [138]. - Rising labor costs are a concern for the company, which is implementing measures to stabilize its management team and enhance talent acquisition to mitigate potential profit declines [142].
扬帆新材:监事会议事规则
2024-04-23 13:43
监事会议事规则 浙江扬帆新材料股份有限公司 (2024 年 4 月) 第一章 总 则 第一条 为规范浙江扬帆新材料股份有限公司(以下简称"公司")的监事会的 议事方式和表决程序,促使监事和监事会有效地履行监督职责,完善公司法人治理 结构,根据《中华人民共和国公司法》(以下简称"《公司法》")、《中华人民 共和国证券法》(以下简称"《证券法》")、《浙江扬帆新材料股份有限公司章 程》(以下简称"《公司章程》")的有关规定,遵照《上市公司治理准则》、《深 圳证券交易所创业板股票上市规则》、《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》的相关要求,制订本规则。 第二章 监事会职权与构成 第二条 监事会依照法律、行政法规、《公司章程》及本规则的相关规定行使职 权。 第三条 监事会由 3 名监事组成,监事会设主席 1 人。监事会主席由全体监事过 半数选举产生。 监事会主席兼任监事会办公室负责人,保管监事会印章。监事会主席可以要求 公司相关人员协助其处理监事会日常事务。 公司监事由股东代表和公司职工代表组成。公司职工代表担任的监事不低于监 事人数的三分之一。公司职工代表担任的监事由公司职工通过 ...